235 related articles for article (PubMed ID: 10801796)
1. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.
Ambrosetti DC; Schöler HR; Dailey L; Basilico C
J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
Ambrosetti DC; Basilico C; Dailey L
Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393
[TBL] [Abstract][Full Text] [Related]
3. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
Yuan H; Corbi N; Basilico C; Dailey L
Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
[TBL] [Abstract][Full Text] [Related]
4. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.
Nowling T; Bernadt C; Johnson L; Desler M; Rizzino A
J Biol Chem; 2003 Apr; 278(16):13696-705. PubMed ID: 12488456
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the FGF-4 gene by a complex distal enhancer that functions in part as an enhanceosome.
Luster TA; Rizzino A
Gene; 2003 Dec; 323():163-72. PubMed ID: 14659890
[TBL] [Abstract][Full Text] [Related]
6. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.
Dailey L; Yuan H; Basilico C
Mol Cell Biol; 1994 Dec; 14(12):7758-69. PubMed ID: 7969117
[TBL] [Abstract][Full Text] [Related]
7. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
8. Spatially precise DNA bending is an essential activity of the sox2 transcription factor.
Scaffidi P; Bianchi ME
J Biol Chem; 2001 Dec; 276(50):47296-302. PubMed ID: 11584012
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex.
Williams DC; Cai M; Clore GM
J Biol Chem; 2004 Jan; 279(2):1449-57. PubMed ID: 14559893
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor Sox-2 inhibits co-activator stimulated transcription.
Bernadt CT; Nowling T; Rizzino A
Mol Reprod Dev; 2004 Nov; 69(3):260-7. PubMed ID: 15349837
[TBL] [Abstract][Full Text] [Related]
11. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR
Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510
[TBL] [Abstract][Full Text] [Related]
12. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2.
Nishimoto M; Fukushima A; Okuda A; Muramatsu M
Mol Cell Biol; 1999 Aug; 19(8):5453-65. PubMed ID: 10409735
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9.
Kamachi Y; Cheah KS; Kondoh H
Mol Cell Biol; 1999 Jan; 19(1):107-20. PubMed ID: 9858536
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers.
Reményi A; Lins K; Nissen LJ; Reinbold R; Schöler HR; Wilmanns M
Genes Dev; 2003 Aug; 17(16):2048-59. PubMed ID: 12923055
[TBL] [Abstract][Full Text] [Related]
15. Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development.
Kamachi Y; Uchikawa M; Tanouchi A; Sekido R; Kondoh H
Genes Dev; 2001 May; 15(10):1272-86. PubMed ID: 11358870
[TBL] [Abstract][Full Text] [Related]
16. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells.
Chew JL; Loh YH; Zhang W; Chen X; Tam WL; Yeap LS; Li P; Ang YS; Lim B; Robson P; Ng HH
Mol Cell Biol; 2005 Jul; 25(14):6031-46. PubMed ID: 15988017
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of SOX2, Pax6 and Maf transcription factors in the regulation of lens-specific delta1-crystallin enhancer.
Muta M; Kamachi Y; Yoshimoto A; Higashi Y; Kondoh H
Genes Cells; 2002 Aug; 7(8):791-805. PubMed ID: 12167158
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the Oct-3/4 gene in cell culture model systems that parallel different stages of mammalian development.
Mallanna SK; Boer B; Desler M; Rizzino A
Mol Reprod Dev; 2008 Aug; 75(8):1247-57. PubMed ID: 18213644
[TBL] [Abstract][Full Text] [Related]
20. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
